INJECTION
DUAL CHAMBER
FORMULATION
PFS
WEARABLES
ALL INJECTION
OCULAR
ORAL
RESPIRATORY
PULMONARY
NASAL
ALL RESPIRATORY
SKIN
SUSTAINABILITY
MORE
INTERVIEWS
EXPERT VIEWS
EARLY INSIGHTS
COMPANY LISTINGS
OUR AUTHORS
THE MAGAZINE
EVENTS
ED CALENDAR
CONTRIBUTE
MEDIA PACK 2027
Subscribe
INJECTION
DUAL CHAMBER
FORMULATION
PFS
WEARABLES
ALL INJECTION
OCULAR
ORAL
RESPIRATORY
PULMONARY
NASAL
ALL RESPIRATORY
SKIN
SUSTAINABILITY
MORE
INTERVIEWS
EXPERT VIEWS
EARLY INSIGHTS
COMPANY LISTINGS
OUR AUTHORS
THE MAGAZINE
EVENTS
ED CALENDAR
CONTRIBUTE
MEDIA PACK 2027
SEARCH
SEARCH
advanced search
SUSTAINABILITY
EXPERT VIEW
THE OVERLOOKED SUSTAINABILITY LEVER: HUMAN FACTORS IN DRUG DELIVERY
Adrian Segens and Robin Huedepohl consider the effects of device design choices on environmental impact, looking at how design decisions can be optimised to reduce drug or device wastage, improve benefits for patients and ultimately minimise carbon footprints.
EXPERT VIEW
DESIGNING FOR A WORLD UNDER STRAIN: THE ROLE OF ECO-DESIGN IN IMPROVING SUSTAINABILITY AND SUPPLY-CHAIN SECURITY
Rob Veasey discusses the core concepts of eco-design as applied to drug delivery devices, examining how sustainability principles can improve not only the environmental impact of the industry’s products and processes but also how they can contribute to better supply-chain robustness and resilience.
SUSTAINABILITY
Yann Fromont
Aptar Pharma
BRINGING PHARMACEUTICAL ELASTOMER WASTE INTO A CIRCULAR ECONOMY
Yann Fromont and Clovis Saunier discuss Aptar Pharma and Moine Recyclage's partnership and explain how clean elastomer production scrap from the manufacture of injectable components is recovered and repurposed for durable technical applications.
SUSTAINABILITY
Erik Schwartz
SABIC
NON-PTFE, NIA-PFAS POLYMERS FOR LIQUID DRUG DELIVERY DEVICES
Dr Erik Schwartz, Dirk van Oevelen and Anton Petrov discuss SABIC’s range of NIA-polyfluoroalkyl polymers and introduce the company’s fully functional autoinjector prototype, which uses the latest generation of resins and compounds from different polymer families.
SUSTAINABILITY
Cristin Konkart
Ypsomed
A CALCULATED MOVE: PUTTING ENVIRONMENTAL ASSESSMENT DATA TO WIDER USE
Cristin Konkart and Shawn James investigate the importance of the underlying methodologies and expertise behind product carbon footprints and lifecycle assessments, drawing on Ypsomed’s accrued organisational expertise to demonstrate how these processes are evolving and providing greater value to the company and its partners.
EXPERT VIEW
Athanasios Garoufas
WHY THE GREENEST POLYMERS NEVER REACHED SCALE
Athanasios Garoufas and Laura Armenio discuss how the sustainability profile of a material is baked-in at its production, examining how traditional methods for producing polymers fail to unify both environmentally favourable feedstock and industrial-scale production capacity, and consider the advantages that next-generation methods that bring these two key aspects together could bring to not only drug delivery but the wider industry.
SUSTAINABILITY
Darren Bromley-Davenport
Orbia Fluor & Energy Materials
MANUFACTURERS’ ROLE IN DELIVERING ESSENTIAL RESPIRATORY HEALTHCARE DURING THE TRANSITION TO LOW-GWP pMDIs
Darren Bromley-Davenport of Orbia Fluor & Energy Materials discusses the transition from current hydrofluoroalkane propellants to lower global warming potential alternatives for use in metered dose inhalers, highlighting the services that the company can offer the industry via its GMP facilities and wealth of experience to ensure that the transition is as smooth as possible.
SUSTAINABILITY
Tony Mallett
Bespak
DESIGNING WITH SUSTAINABILITY IN MIND: ENGINEERING LOW CARBON pMDIs FROM THE COMPONENT UP
Tony Mallett and Richard Turner explain the environmental strategies that shape inhalation device development and commercial manufacture when designing for propellants with low global warming potential, allowing patients to receive safe and effective treatment with lower environmental impact.
EXPERT VIEW
Dr Bettine Boltres
THE SUSTAINABILITY ESCAPE ROOM: HOW PRIMARY PACKAGING TRIES TO GET OUT OF THE EU REGULATORY MAZE
Dr Bettine Boltres, Joe Monfort and Dana Smith break down the key EU regulatory layers affecting primary pharmaceutical packaging authorisations and explain why sustainability decisions require lifecycle thinking rather than single-attribute claims.
EXPERT VIEW
Dr Frank Engel Rasmussen
REDUCING COMMERCIALISATION RISK IN DRUG DELIVERY DEVELOPMENT
Dr Frank Engel Rasmussen and Mark Ypsilantis discuss how early decisions on functional device design affect downstream production choices, highlighting the importance of integrating scale-up considerations from the outset, across all development teams.
EXPERT VIEW
Serena Grace
BIOPLASTICS IN DRUG DELIVERY: SUSTAINABLE SOLUTION OR SUBSTITUTION TRAP?
Serena Grace and Alex Fong examine the environmental and supply-chain limits of bio-based plastics in drug delivery, arguing that material substitution alone cannot address the sector’s deep dependence on virgin plastics. They consider how reducing raw material dependence can contribute not only to lowering carbon footprints but also to increasing supply-chain resilience, and highlight the importance of assessing, not assuming, impact.
PREFILLED SYRINGES
Dr Jakob Lange
Ypsomed
FOR THE RECORD: HOW PAST EXPERIENCE ENABLES FUTURE SUCCESS
Dr Jakob Lange and Shawn James discuss the value of the experience hidden behind metrics such as completed projects and commercialised devices – the wealth of accumulated process knowledge that enables a company to bring hard-learned lessons forwards to benefit each new development programme and evolve its product portfolio to meet the needs of an evolving sector.
INTERVIEW
Michael Earl
Eco-inject
Interview: Eco-Inject: Bringing Affordable Sustainability to Single-Use Disposable Autoinjectors
In this exclusive interview, Michael Earl and Steven Kaufman speak about the significant progress Eco-Inject has made throughout 2026 since its highly successful funding round earlier in the year, discussing what’s new in the world of Eco-Inject, what sets the device platform apart from other approaches to sustainability in the autoinjector space, and how the industry is reacting to Eco-Inject as it moves towards the market.
CONFERENCE SHOWCASE
CPHI Milan 2026 Programme to Feature >260 Speakers, and First Sustainability Summit Launches
Eli Lilly's manufacturing chief to headline a three-day conference programme built around real-world industry challenges and trends, and a brand new two-day Sustainability Summit launches on Day 1 of the show.
SUSTAINABILITY
Serena Grace
Owen Mumford
REAL-TIME LCAs: CREATING “A SINGLE SOURCE OF TRUTH” FOR SUSTAINABILITY
Serena Grace and Marina Dumont offer insight into the development of a real-time operational model for lifecycle assessments, and detail how organisations can transform these analyses into robust decision-making tools.
EXPERT VIEW
Henryk Badack
MAINTAINING RELIABLE DRUG DELIVERY THROUGH SUSTAINABLE OPERATIONS
Henryk Badack considers how a holistic approach to sustainability can enable CDMOs to implement efficient operations strategically – while introducing initiatives that address environmental, economic and social elements.
EXPERT VIEW
Kiara Taylor
LATE-STAGE MATERIAL SUBSTITUTION: AMBITION FOR SUSTAINABILITY OR TRANSFER-TIME RISK?
Kiara Taylor delves into the challenges of changing materials to enhance sustainability after a design has been transferred to manufacturing, considering the reasons that might drive such a change, the issues involved and the benefits that can be gained.
SUSTAINABILITY
Nadine Kaufmann
Ypsomed
BIO-BASED PLASTICS IN DRUG DELIVERY: FROM MATERIAL EQUIVALENCE TO SYSTEMIC DECARBONISATION
Nadine Kaufmann and Michael Schori analyse the feasibility of introducing sustainable materials within current regulatory frameworks, demonstrating this with a range of Ypsomed products and illustrating ways to further integrate sustainable principles into the value chain.
EXPERT VIEW
Adam Tilley
SUSTAINABILITY IN DRUG DELIVERY
Adam Tilley and David Cook explore how carbon footprint considerations can be integrated into the drug delivery device design lifecycle, highlighting key sustainability decisions faced by design engineers and emerging tools that support those evaluations.
INTERVIEW
Prof Hanns-Christian Mahler
ten23 health
Exclusive Interview: Taking Sustainability Beyond Compliance
Prof Hanns-Christian Mahler engages in a wide-ranging discussion about current challenges and trends in the drug delivery industry, particularly on the topic of sustainability – it’s advantages, difficulties and why companies should aim to do more than the bare minimum required by the regulation.
SUSTAINABILITY
Dr Bernd Garska
Covestro LLC
RETHINKING DRUG DELIVERY: ENABLING RECYCLING AND MATERIAL EFFICIENCY IN HEALTHCARE
Dr Bernd Garska and Sven Schlecht highlight how single-use drug delivery devices can be re-thought to help solve the climate and environmental challenges in the healthcare sector.
SUSTAINABILITY
Lionel Maritan
ARaymond
ECO-DESIGN DRIVING NEST AND READY-TO-USE PACKAGING INNOVATION
Lionel Maritan and François Ciavatti discuss RayDyLyo
®
, an eco-designed nest developed to reduce the overall impact of ready-to-use components, reflecting on insights gained from lifecycle assessments, outlining the progress still to be made and illustrating how a pragmatic, inventive, eco-centric design approach can drive the development of packaging solutions with a measurably lower environmental footprint.
EXPERT VIEW
Greg Anderson
CHALLENGES & OPPORTUNITIES TO OPTIMISE SUSTAINABILITY IN PHARMACEUTICAL PACKAGING & COMBINATION DEVICES
Greg Anderson discusses the need to improve the sustainability and circularity of pharmaceutical packaging and drug delivery devices, looking at the challenges and providing a clear outline of the potential opportunities for improvement.
SUSTAINABILITY
Chris Baron
Aptar Pharma
REINVENTING THE pMDI: EVOLVING A PROVEN PLATFORM FOR A LOW-GWP FUTURE
Chris Baron discusses how lower-global warming potential pressurised metered dose inhalers are moving from development to commercialisation and explains why manufacturing readiness and supply resilience are critical, going on to introduce Aptar Pharma’s ZEN30 Futurity
®
, designed to anticipate current and emerging regulatory expectations.
EXPERT VIEW
Markus Laubscher
ENABLING A SUSTAINABLE FUTURE FOR pMDIs WITH LOW-GWP MEDICAL PROPELLANTS
Markus Laubscher discusses the role of pressurised metered dose inhalers in the context of healthcare’s drive towards sustainability, considering the need for lower-global-warming-potential propellants and why it is important to preserve these inhalers as a key aspect of respiratory care.
SUSTAINABILITY
Thomas Daly
Bespak
THE PHYSICS OF THE SWITCH: OPTIMISING pMDI DESIGN FOR LOW-CARBON LUNG DELIVERY
Thomas Daly and Tony Mallett discuss the transition to low-global warming potential propellants, examining the vital adjustments to the whole inhalation system necessary to support effective and safe dosing without hydrofluorocarbons.
1
2
3
…
7
Next
Top
